Transition Therapeutics to raise up to $30.8 mln in private placement
Transition Therapeutics Inc (NASDAQ: TTHI, TSX: TTH), a biopharmaceutical company based in Toronto, said Friday that it is raising up to US$30.8 million of equity in a private placement. The investors will include U.S. investment firm Oracle Investment Management, Jack W. Schuler, Larry N. Feinberg and other previous backers. According to details of the transaction, Transition Therapeutics will sell over 3.1 million units of its company at US$5.32 per unit. The private placement deal is expected to close on or about June 20, 2014.
6 June 2014•3 mins read
